Clinical Evaluation of RTX Locator Attachments for Implant-supported Mandibular Complete Overdenture

Sponsor
Mansoura University (Other)
Overall Status
Completed
CT.gov ID
NCT05290376
Collaborator
(none)
30
1
2
20.2
1.5

Study Details

Study Description

Brief Summary

This study was conducted to clinically and radiographically evaluate locator RTx attachments for two implant-supported mandibular overdenture using two loading protocols

Condition or Disease Intervention/Treatment Phase
  • Procedure: surgical placement of long dental implants
  • Device: overdenture supported by RTX attachment system
N/A

Detailed Description

Thirty edentulous patients received two implants in the interformaninal region in the canine area . According to the loading protocol used for attaching mandibular overdenture, patients were randomly assigned into two equal groups. Group I (control): patients who would be delivered mandibular implant overdenture retained by two RTx locator attachments using conventional loading protocol. Group II (study): patients who would be delivered mandibular overdenture retained by two RTx locator attachments using early loading protocol. Peri-implant tissue health [Plaque (PL) and (GI) gingival scores, pocket depth (PD), and crestal bone loss (CBL)] were evaluated immediately after denture insertion (T0), 6 (T6), and 12 (T12) months after insertion.

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Patients were randomly assigned into two equal groups. Group I (control): patients who would be delivered mandibular implant overdenture retained by two RTX locator attachments using conventional loading protocol. Group II (study): patients who would be delivered mandibular overdenture retained by two RTx locator attachments using early loading protocol.Patients were randomly assigned into two equal groups. Group I (control): patients who would be delivered mandibular implant overdenture retained by two RTX locator attachments using conventional loading protocol. Group II (study): patients who would be delivered mandibular overdenture retained by two RTx locator attachments using early loading protocol.
Masking:
Double (Participant, Outcomes Assessor)
Masking Description:
The selected patients were stratified according to age, gender, years of mandibular edentulism, number of old non-satisfactory dentures (baseline criteria, table 1). Patients were assigned to one of 2 groups using a balanced randomization procedure to ensure comparability between groups regarding baseline characters;
Primary Purpose:
Treatment
Official Title:
Clinical Evaluation of RTX Locator Attachments for Implant-supported Mandibular Complete Overdenture Using Two Loading Protocols
Actual Study Start Date :
Jan 15, 2020
Actual Primary Completion Date :
Dec 15, 2020
Actual Study Completion Date :
Sep 20, 2021

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Control group

Group I (control): patients who would be delivered mandibular implant overdenture retained by two RTx locator attachments using conventional loading protocol

Procedure: surgical placement of long dental implants
Two interforaminal implants were placed in the canine region

Device: overdenture supported by RTX attachment system
Control group: Implants were loaded after three months by RTX supported overdenture study group: Implants were loaded after four weeks by RTX supported overdenture

Active Comparator: Study group

Group II (study): patients who would be delivered mandibular overdenture retained by two RTx locator attachments using early loading protocol.

Procedure: surgical placement of long dental implants
Two interforaminal implants were placed in the canine region

Device: overdenture supported by RTX attachment system
Control group: Implants were loaded after three months by RTX supported overdenture study group: Implants were loaded after four weeks by RTX supported overdenture

Outcome Measures

Primary Outcome Measures

  1. Marginal bone loss [one year]

    evaluations of crestal bone loss in mm around implants by digital periapical radiography

  2. plaque score [one year]

    evaluation of plaque accumulation around RTX attachments using scores.score 0; absence plaque , score 1; plaque only detected by a probe passing through the smooth marginal surface of the implant, score 2; plaque can be recognized by naked eye, and score 3; plenty of soft matter.

  3. gingival index [one year]

    evaluation of gingival bleeding around RTX attachments using scores.0; no bleeding when a periodontal probe is passed along the mucosal margin, 1;isolated bleeding spots visible, 2; blood forms a confluent red line on the mucosal margin, 3;heavy or profuse bleeding.

  4. pocket depth [one year]

    evaluation of pocket depth in mm around RTX attachments

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • adequate bone quantity [class III -V according to Cawood and Howell in the interforaminal area of the mandible to receive 2 implants (4×13 mm)

  • adequate restorative space [12-15 mm from the mucosa of the mandibular ridge to the occlusal plane, Class I according to Ahuja and Cagna for RTX supported implant overdenture.

Exclusion Criteria:
  • systemic diseases that contraindicate implant placement

  • bone metabolic diseases as diabetes mellitus

  • irradiation of the head and neck region

  • chemotherapy within the past 3 years

  • smoking habits.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Christine Ibrahim Mansoura Egypt P.O.Box:35516

Sponsors and Collaborators

  • Mansoura University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mansoura University
ClinicalTrials.gov Identifier:
NCT05290376
Other Study ID Numbers:
  • A03110220
First Posted:
Mar 22, 2022
Last Update Posted:
Mar 22, 2022
Last Verified:
Dec 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 22, 2022